On August 5, 2021, Genomictree Inc. (KOSDAQ:A228760) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,800 KRW | -2.12% | -5.88% | +0.97% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.97% | 371M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Genomictree Inc. announced that it has received KRW 5.00000105 billion in funding from ORION Holdings Corp.